Technology
The company is adding three nutrition tools to its platform that allow providers to supply food recommendations, recipes and tailored grocery lists to their patients.
The company's product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
Also, Jolly Good has collaborated with Brigham and Women's Hospital to create medical education VR content.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
It also received backing from the founding members of Grab and Zalora.
The acquisition includes Mindstrong's technology assets and some of its employees.
The program will be available through Amwell in the second half of 2023.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.